Aviance Capital Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.13M Buy
45,369
+33,798
+292% +$2.33M 0.41% 55
2025
Q1
$803K Hold
11,571
0.11% 167
2024
Q4
$995K Sell
11,571
-5,520
-32% -$475K 0.14% 146
2024
Q3
$2.04M Buy
17,091
+770
+5% +$91.7K 0.27% 93
2024
Q2
$2.33M Buy
16,321
+98
+0.6% +$14K 0.33% 75
2024
Q1
$2.08M Buy
16,223
+1,017
+7% +$131K 0.31% 80
2023
Q4
$1.57M Buy
15,206
+5,000
+49% +$517K 0.34% 69
2023
Q3
$928K Sell
10,206
-4,000
-28% -$364K 0.21% 125
2023
Q2
$1.15M Hold
14,206
0.24% 119
2023
Q1
$1.13M Sell
14,206
-2,000
-12% -$159K 0.25% 111
2022
Q4
$1.1M Buy
16,206
+8,000
+97% +$541K 0.26% 111
2022
Q3
$409K Hold
8,206
0.1% 183
2022
Q2
$457K Hold
8,206
0.1% 185
2022
Q1
$456K Hold
8,206
0.08% 190
2021
Q4
$460K Hold
8,206
0.08% 196
2021
Q3
$394K Hold
8,206
0.07% 207
2021
Q2
$344K Buy
8,206
+1,124
+16% +$47.1K 0.06% 211
2021
Q1
$239K Hold
7,082
0.05% 246
2020
Q4
$247K Hold
7,082
0.05% 236
2020
Q3
$246K Hold
7,082
0.06% 225
2020
Q2
$232K Hold
7,082
0.06% 219
2020
Q1
$213K Hold
7,082
0.07% 198
2019
Q4
$205K Buy
+7,082
New +$205K 0.05% 217
2016
Q1
Sell
-7,000
Closed -$203K 210
2015
Q4
$203K Buy
+7,000
New +$203K 0.07% 180